immune checkpoint play import role regal block cell membrane promise strategy treatment cancer base monoclonal antibody much rapid develop cola cytotox lymphocyte antigen pd program death protein cost prepare high therapeutic effect still restrict recent semi soluble found scale spd function part product differ way secret cell more diffs serum revid demons involve post neg chang plasma level affect prognosis since endowed molecule induce immunology reject human be might make deficit enhance until value therefore increase need investing novel function develop elev therapy future review describe product meghan various checkpoint receptor ligand discus biology signifies regard biomass potent candid drug target topic 